Business context and reporting period
T Stamp Inc. (Nasdaq: IDAI) reported on October 9, 2026 that it entered into an Equity Distribution Agreement with Maxim Group LLC. The filing concerns a potential equity financing, not a quarterly or annual operating-results report.
Potential offering and key terms
- The company may offer and sell up to $5,323,474 of common stock through Maxim, as agent or principal, under an at-the-market program or other legally permitted methods.
- Maxim receives a commission of 3.0% of gross proceeds from each sale. The company also agreed to reimburse specified expenses of up to $40,000 in aggregate, plus up to $3,000 quarterly for Maxim’s counsel fees and incidental expenses.
- The company is not required to sell shares, and the filing gives no assurance that sales will occur or specifies their timing, price, or amount.
- Sales are subject to the effective Form S-3 registration statement and applicable “baby shelf” limitations. The registration statement was declared effective April 30, 2026; the ATM prospectus supplement was filed October 9, 2026.
- The agreement provides for indemnification and contribution to Maxim for certain liabilities and may be terminated by mutual agreement with 15 days’ written notice.
Financial metrics and comparison
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics. It contains no comparable-period results and does not report that any shares have been sold under the agreement.
Outlook, risks, and unusual items
No financial guidance or operating outlook is provided. If shares are sold, the offering could dilute existing stockholders; proceeds, sale prices, timing, and actual dilution are not stated. The filing also notes that actual outcomes may differ from forward-looking statements due to risks described in the company’s other SEC filings. The “baby shelf” limitations may constrain the amount available for sale.
Investor verification checklist
- Check subsequent SEC filings and prospectus supplements for actual shares sold, gross proceeds, sale prices, and remaining offering capacity.
- Verify applicable Form S-3 baby-shelf limits and the company’s available capacity at the time of any sales.
- Assess the resulting share-count increase and dilution, as well as offering commissions and reimbursed expenses.
- Review the full Equity Distribution Agreement and the company’s latest financial statements for liquidity needs and intended use of any proceeds.